Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-05

Clinical Trial Update: A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing CT-P43 to Stelara in patients with plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CT-P43
  • Stelara (ustekinumab)

Snippet

Sponsor: Celltrion | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2023-06-05